Research map: Increased risk of respiratory syncytial virus infection in patients with active inflammatory bowel disease: a matched cohort study

Back to the article

Papers in this map

  1. An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease · Nicholas Joseph Talley · 2011 · 311 citations · Cited by this paper
  2. Modified Crohn's Disease Exclusion Diet and exclusive enteral nutrition (EEN) resolve oral dysbiosis in pediatric Crohn's disease: a prospective cohort study · Gary P. Moran · 2026 · 1 citation · Related
  3. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary · David T. Rubin · 2020 · 235 citations · Cited by this paper
  4. Interpreting oral dysbiosis during nutritional therapy in pediatric Crohn disease · Huan Xu · 2026 · Related
  5. Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice · Stefano Bruscoli · 2021 · 217 citations · Cited by this paper
  6. Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study · 2026 · Related
  7. Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 · Amadea Britton · 2024 · 179 citations · Cited by this paper
  8. Mast cell–derived IL-13 as a driver of Crohn disease–associated intestinal fibrosis · 2026 · Related
  9. Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection · Rebecca C. Woodruff · 2024 · 133 citations · Cited by this paper
  10. Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments · 2026 · Related
  11. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis · Amanda B. Payne · 2024 · 132 citations · Cited by this paper
  12. Transmural healing is significantly associated with prevention of clinical relapse in Crohn’s disease · 2026 · Related
  13. COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses · Filippo Fagni · 2021 · 122 citations · Cited by this paper
  14. Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial · 2026 · Related
  15. Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023 · Fiona P. Havers · 2023 · 91 citations · Cited by this paper
  16. Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD · 2026 · Related
  17. Respiratory syncytial virus infections in adults: a narrative review · Joanne Wildenbeest · 2024 · 89 citations · Cited by this paper
  18. Inflammatory bowel disease in the aging population · 2026 · Related
  19. Burden of Respiratory Syncytial Virus–Associated Hospitalizations in US Adults, October 2016 to September 2023 · Fiona P. Havers · 2024 · 84 citations · Cited by this paper
  20. Inflammatory bowel disease and risk of perineal injury in primiparous vaginal births: a retrospective cohort study · 2026 · Related
  21. Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease · Tushar Shukla · 2016 · 55 citations · Cited by this paper
  22. AGA Clinical Practice Update on Noncolorectal Cancer Screening and Vaccinations in Patients With Inflammatory Bowel Disease: Expert Review · Freddy Caldera · 2025 · 42 citations · Cited by this paper
  23. ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease · Francis A. Farraye · 2025 · 41 citations · Cited by this paper
  24. Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections · Carolina Aliai Micol Cavalli · 2023 · 40 citations · Cited by this paper
  25. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic · Simeng Lin · 2022 · 34 citations · Cited by this paper
  26. Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials · Brian G. Feagan · 2018 · 27 citations · Cited by this paper
  27. Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide study · Karl Mårild · 2022 · 23 citations · Cited by this paper
  28. Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus · Ryan A. Smith · 2024 · 19 citations · Cited by this paper
  29. From Cytokines to Biomarkers: Mapping the Immunopathology of Inflammatory Bowel Disease · Sarah Baum · 2025 · 17 citations · Cited by this paper
  30. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic · Sara El Ouali · 2021 · 10 citations · Cited by this paper
  31. Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence · Susanna Esposito · 2022 · 9 citations · Cited by this paper
  32. A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk · Karl Mårild · 2024 · 9 citations · Cited by this paper
  33. From Gut to Lungs: The Hidden Respiratory Impacts of IBD: A Systematic Review of the Literature · Ionela Preotesoiu · 2025 · 8 citations · Cited by this paper
  34. Patients With Inflammatory Bowel Disease Are at Increased Risk of Respiratory Syncytial Virus Infections After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Propensity-Matched Cohort Analysis · Saqr Alsakarneh · 2025 · 4 citations · Cited by this paper
  35. Impact of tobacco use on inpatient outcomes in inflammatory bowel disease: a retrospective matched cohort study · Mohamed H. Eldesouki · 2026 · 3 citations · Cited by this paper
  36. Severe Influenza-Related Outcomes in Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy: A Propensity-Matched Cohort Analysis · Mohamed H. Eldesouki · 2026 · 3 citations · Cited by this paper
  37. COVID-19 and inflammatory bowel disease — what to know · Anne Godat · 2025 · 2 citations · Cited by this paper
  38. Untitled · Cited by this paper

Source: OpenAlex (CC0)